Showing 15,581 - 15,600 results of 103,692 for search '(( 50 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.35s Refine Results
  1. 15581

    Critical Fluctuations in Plasma Membrane Vesicles by Sarah L. Veatch (180783)

    Published 2008
    “…We demonstrate critical behavior in giant plasma membrane vesicles (GPMVs) that are isolated directly from living cells. …”
  2. 15582

    Critical Fluctuations in Plasma Membrane Vesicles by Sarah L. Veatch (180783)

    Published 2008
    “…We demonstrate critical behavior in giant plasma membrane vesicles (GPMVs) that are isolated directly from living cells. …”
  3. 15583
  4. 15584

    H12 values in sweeps of varying softness. by Nandita R. Garud (694498)

    Published 2015
    “…Each data point was averaged over 1000 simulations. H12 values rapidly decline as the softness of a sweep increases and as the ending partial frequency of the adaptive allele decreases. …”
  5. 15585
  6. 15586
  7. 15587

    Earth-Abundant Fe and Ni Dually Doped Co<sub>2</sub>P for Superior Oxygen Evolution Reactivity and as a Bifunctional Electrocatalyst toward Renewable Energy-Powered Overall Alkalin... by Jiangtian Li (1284543)

    Published 2021
    “…The FeNi-Co<sub>2</sub>P||FeNi-Co<sub>2</sub>P and FeNi-Co<sub>2</sub>P||Ni-Co<sub>2</sub>P electrolyzer cells demonstrate voltages of 1.596 and 1.578 V at 10 mA/cm<sup>2</sup> for water splitting in 1 M KOH, respectively. …”
  8. 15588

    Earth-Abundant Fe and Ni Dually Doped Co<sub>2</sub>P for Superior Oxygen Evolution Reactivity and as a Bifunctional Electrocatalyst toward Renewable Energy-Powered Overall Alkalin... by Jiangtian Li (1284543)

    Published 2021
    “…The FeNi-Co<sub>2</sub>P||FeNi-Co<sub>2</sub>P and FeNi-Co<sub>2</sub>P||Ni-Co<sub>2</sub>P electrolyzer cells demonstrate voltages of 1.596 and 1.578 V at 10 mA/cm<sup>2</sup> for water splitting in 1 M KOH, respectively. …”
  9. 15589

    Earth-Abundant Fe and Ni Dually Doped Co<sub>2</sub>P for Superior Oxygen Evolution Reactivity and as a Bifunctional Electrocatalyst toward Renewable Energy-Powered Overall Alkalin... by Jiangtian Li (1284543)

    Published 2021
    “…The FeNi-Co<sub>2</sub>P||FeNi-Co<sub>2</sub>P and FeNi-Co<sub>2</sub>P||Ni-Co<sub>2</sub>P electrolyzer cells demonstrate voltages of 1.596 and 1.578 V at 10 mA/cm<sup>2</sup> for water splitting in 1 M KOH, respectively. …”
  10. 15590

    Synergistic Interaction of Hyperbranched Polyglycerols and Cetyltrimethylammonium Bromide for Oil/Water Interfacial Tension Reduction: A Molecular Dynamics Study by James Moraes de Almeida (10986250)

    Published 2023
    “…Experimentally, the combination of hyperbranched polyglycerol (HPG) with cetyltrimethylammonium bromide (CTAB) substantially reduced the observed IFT of oil/water interface, 0.9 mN/m, while HPG alone was 5.80 mN/m and CTAB alone IFT was 8.08 mN/m. Previous simulations in an aqueous solution showed that HPG is a surfactant carrier. …”
  11. 15591

    Inositol Polyphosphate-4-Phosphatase Type I Negatively Regulates Phagocytosis via Dephosphorylation of Phagosomal PtdIns(3,4)P<sub>2</sub> by Kiyomi Nigorikawa (340973)

    Published 2015
    “…Inpp4a was recruited to the phagosome membrane by a mechanism other than the direct interaction with Rab5. …”
  12. 15592

    Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells by Magdalena Circu (4458754)

    Published 2017
    “…Cisplatin IC<sub>50</sub> in A549Pt (parental) and A549cisR (cisplatin resistant) cells was 13 μM and 47 μM, respectively. …”
  13. 15593
  14. 15594

    table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  15. 15595

    table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  16. 15596

    image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  17. 15597

    table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  18. 15598

    image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  19. 15599

    table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

    Published 2021
    “…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”
  20. 15600

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…</p><p>Smooth muscle contraction is a known to be promoted by lysophosphatidic acid. In this study, we showed that dosing rats with ONO-8430506 decreased intraurethral pressure accompanied by urethral relaxation. …”